Bloomberg Businessweek cover image

Facebook in the Spotlight

Bloomberg Businessweek

00:00

Do You Think the FDA Will Approve Monveraper?

Hazelten: There are several concerns. Number one concerned is, will you mutate sars covid is something worse than it is? That is a real danger. We don't want somebody taking a small dose, by accident of the drug and mutating it. So it doesn't die, but it just gets worseo anyido, i think the fda has got to be very, very cautious in their approval of this drug.

Play episode from 02:49
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app